ArticleHemoglobin2021
Utilization of Pneumococcal Vaccine and Penicillin Prophylaxis in Sickle Cell Disease in Three African Countries: Assessment among Healthcare Providers in SickleInAfrica.
Open access · greenAbstract read
In one paragraph
Article in Hemoglobin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 12 citations in OpenAlex.
- The Epidemiology of Sickle Cell Disease in Sub-Saharan Africa: Current Knowledge and Gaps to be Filled.American journal of hematology · 2026Review
- Experience in the adoption of Research Electronic Data Capture (REDCap) as a tool for medical research in Tanzania.medRxiv : the preprint server for health sciences · 2025Article
- Infections in sickle cell disease.Haematologica · 2025Review
- Childhood vaccination trends during 2019 to 2022 in Tanzania and the impact of the COVID-19 pandemic.Human vaccines & immunotherapeutics · 2024Article
- Article
- A Newborn Screening Program for Sickle Cell Disease in Murcia (Spain).International journal of neonatal screening · 2023Article
- Review
- Current challenges and new approaches to implementing optimal management of sickle cell disease in sub-Saharan Africa.Seminars in hematology · 2023Article
- Sickle Cell Disease in Children and Adolescents: A Review of the Historical, Clinical, and Public Health Perspective of Sub-Saharan Africa and Beyond.International journal of pediatrics · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors at 14 institutions in 6 countries.
Biobele J BrownDepartment of Paediatrics, Haematology & Oncology Unit, College of Medicine, University of Ibadan & University College Hospital, Ibadan, Nigeria.
Anazoeze MaduDepartment of Haematology, University of Nigeria, Nsukka, Nigeria.
Raphael Z SangedaDepartment of Pharmaceutical Microbiology, Muhimbili University of Health & Allied Sciences, Dar es Salaam, Tanzania.
Siana NkyaDepartment of Biological Sciences, Dar es Salaam University College of Education, Dar es Salaam, Tanzania.
Emmanuel PeprahDepartment of Social & Behavioral Sciences, New York University School of Global Public Health, New York, NY, USA.
Vivian PaintsilDepartment of Child Health, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Bruno P MmbandoTanga Research Centre, National Institute for Medical Research, Tanga, Tanzania.
Joyce GyamfiDepartment of Social & Behavioral Sciences, New York University School of Global Public Health, New York, NY, USA.
Chide E OkochaDepartment of Haematology, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
Samuel A AsalaCentre of Excellence for Sickle Cell Disease Research & Training, University of Abuja, Abuja, Nigeria.
Victoria NembawareFaculty of Health Sciences, Department of Pathology, Division of Human Genetics, University of Cape Town, Cape Town, South Africa.
Mario JonasFaculty of Health Sciences, Department of Pathology, Division of Human Genetics, University of Cape Town, Cape Town, South Africa.
Andre P KengneNon-Communicable Diseases Research Unit, South African Medical Research Council & Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Emile R ChimusaFaculty of Health Sciences, Department of Pathology, Division of Human Genetics, University of Cape Town, Cape Town, South Africa.
Arthemon NguwenezaFaculty of Health Sciences, Department of Pathology, Division of Human Genetics, University of Cape Town, Cape Town, South Africa.
Hezekiah A IsaCentre of Excellence for Sickle Cell Disease Research & Training, University of Abuja, Abuja, Nigeria.
Uche Nnebe-AgumaduDepartment of Paediatrics, University of Abuja Teaching Hospital, Abuja, Nigeria.
Adekunle D AdekileFaculty of Medicine, Department of Paediatrics, Kuwait University, Jabriya, Kuwait.
Alex Osei-AkotoDepartment of Child Health, School of Medicine and Dentistry, Kwame Nkrumah University of Science & Technology, Kumasi, Ghana.
Kwaku Ohene-FrempongSickle Cell Foundation of Ghana, Accra, Ghana.
Emmanuel BalandyaDepartment of Physiology, Muhimbili University of Health & Allied Sciences, Dar es Salaam, Tanzania.
Obiageli E NnoduCentre of Excellence for Sickle Cell Disease Research & Training, University of Abuja, Abuja, Nigeria.ORCID https://orcid.org/0000-0002-4801-3156
Ambroise WonkamFaculty of Health Sciences, Department of Pathology, Division of Human Genetics, University of Cape Town, Cape Town, South Africa.ORCID https://orcid.org/0000-0003-1420-9051
Julie MakaniDepartment of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
SickleInAfrica Consortium
University of Cape Town · ZAMuhimbili University of Health and Allied Sciences · TZUniversity of Abuja · NGNew York University · USKomfo Anokye Teaching Hospital · GHKuwait University · KWKwame Nkrumah University of Science and Technology · GHNational Institute for Medical Research · TZNnamdi Azikiwe University Teaching Hospital · NGSouth African Medical Research Council · ZAUniversity of Abuja Teaching Hospital · NGUniversity of Dar es Salaam · TZUniversity of Ibadan · NGUniversity of Nigeria · NG
Funding
Sickle Africa Data Coordinating CenterU24HL135600 · NHLBI · UNIVERSITY OF CAPE TOWN · PI MULDER, NICOLA, WONKAM, AMBROISE · 2017 to 2025
$8.6MThe Sickle Pan-African Research Consortium (SPARCO)U24HL135881 · NHLBI · MUHIMBILI UNIVERSITY/ ALLIED HLTH SCIS · PI MAKANI, JULIE · 2017 to 2025
$5.3MSickle Pan African Research Consortium NigEria (SPARC-NEt)U01HL156942 · NHLBI · UNIVERSITY OF ABUJA · PI NNODU, OBIAGELI EUNICE · 2021 to 2025
$1.3MNHLBI NIH HHS U01 HL156942NHLBI NIH HHS U24 HL135600NHLBI NIH HHS U24 HL135881
Abstract
Sickle cell disease is a genetic disease with a predisposition to infections caused by encapsulated organisms, especially
Indexed as
Anemia, Sickle CellPenicillinsPneumococcal InfectionsHealth PersonnelHumansNigeriaPneumococcal VaccinesStreptococcus pneumoniaePenicillinsPneumococcal VaccinesBehaviorspenicillin prophylaxissickle cell diseaseSickle Pan-African Research Consortium (SPARCO)
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.